Zimmer Biomet Holdings Inc banner

Zimmer Biomet Holdings Inc
SIX:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
SIX:ZBH
Watchlist
Price: 157 CHF 5.37% Market Closed
Market Cap: CHf21.1B

Wall St Price Targets

ZBH Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBH is 173.32 CHF with a low forecast of 144.08 CHF and a high forecast of 232.99 CHF.

Lowest Forecast
Price Target
144.08 CHF
8% Downside
Average Forecast
Price Target
173.32 CHF
10% Upside
Highest Forecast
Price Target
232.99 CHF
48% Upside
Zimmer Biomet Holdings Inc Competitors:
Price Targets
NKTX
Nkarta Inc
430% Upside
URI
United Rentals Inc
-3% Downside

Revenue
Forecast

4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 7 years is 4%.

Gross Profit
Forecast

4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 5%.

Operating Income
Forecast

2% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-35%
Average Miss
2% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-35%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is 12%.

Pre-Tax Income
Forecast

-1% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss
-1% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 40%.

Net Income
Forecast

-1% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
-1% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 7 years is 19%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZBH's stock price target?
Price Target
173.32 CHF

According to Wall Street analysts, the average 1-year price target for ZBH is 173.32 CHF with a low forecast of 144.08 CHF and a high forecast of 232.99 CHF.

What is the Revenue forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 7 years is 4%.

What is the Gross Profit forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 5%.

What is the Operating Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is 12%.

What is the Pre-Tax Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
40%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 40%.

What is the Net Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
19%

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 7 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett